The differential effects of IL-17 on the expression of chemokines for myeloid cells and lymphocytes provide important clues for its effects on the regulation of myeloid cells and lymphocytes and may be important mechanisms for IL-17 mediated tumor promoting inflammation in DMBA/TPA induced skin tumors. The gene discussed is IL17A; the disease is neoplasm.